Scientists test Next-Gen insulin for faster blood sugar control
NCT ID NCT06809621
Summary
This study tested a new, fast-acting insulin designed for use in insulin pumps by people with type 1 diabetes. Researchers compared how quickly and effectively this new insulin (NNC0471-0119) lowers blood sugar compared to a commonly used insulin (aspart). The study involved 43 adults to measure how the body processes the insulin and to check its safety over 1-3 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.